Summary & Overview
CPT 80321: Alcohol Biomarker Detection and Measurement
CPT code 80321 represents a laboratory assay for detection and measurement of one or two alcohol biomarker compounds in a patient specimen. This code captures tests that identify physiological indicators of alcohol exposure or ingestion and is relevant for clinical toxicology, substance-use monitoring, workplace testing programs, and medico-legal evaluations. Nationally, biomarker testing for alcohol is an element of clinical and occupational care pathways and has implications for laboratory reimbursement, quality reporting, and clinical decision support.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for alcohol biomarker testing, typical sites of service, and payer coverage considerations. The publication outlines common billing modifiers applicable to lab services, common claim adjudication considerations, and where available, benchmark measures for reimbursement and utilization. It also summarizes policy updates affecting laboratory biomarker coding, practical documentation elements tied to clinical indications, and related CPT code relationships.
This summary is intended to inform billing staff, laboratory managers, and policy analysts about the clinical purpose of CPT code 80321, common places the service is performed, and the payer mix relevant to national practice.
Billing Code Overview
CPT code 80321 describes a laboratory service in which a clinical laboratory analyst detects and measures alcohol biomarker compound(s) in a patient specimen. Alcohol biomarkers are physiological indicators of alcohol exposure or ingestion; this test covers detection and quantitative measurement of one or two specific alcohol biomarker compounds in blood, urine, or other suitable clinical specimens.
Service type: Clinical laboratory biomarker assay
Typical site of service: Clinical laboratory or hospital laboratory
Clinical & Coding Specifications
Clinical Context
A typical patient for 80321 is an adult undergoing laboratory testing for alcohol exposure assessment. Common scenarios include pre-employment or workplace screening, monitoring in substance use disorder treatment programs, forensic or legal testing (e.g., probation or custody cases), and clinical evaluation when alcohol ingestion is suspected in the emergency department or inpatient setting. The clinical workflow begins with specimen collection (blood, urine, or other validated matrix) under chain-of-custody when required. The specimen is labeled and delivered to a clinical laboratory. A laboratory analyst performs the 80321 assay to detect and quantify one or two alcohol biomarker compounds (for example ethyl glucuronide [EtG] or ethyl sulfate [EtS], or phosphatidylethanol [PEth] when present), documents results in the laboratory information system, and reports findings to the ordering clinician or program. Results inform clinical decisions such as treatment modification, workplace action, or legal reporting. Typical sites of service include outpatient laboratory collection centers, hospital outpatient laboratories, inpatient hospital laboratories, and specialized forensic collection sites.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Unspecified modifier | Rarely used; not appropriate as a substitute for a specific modifier |